Ikarian Capital’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Ikarian Capital’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-46,066	Closed	-$3.87M	–	237
2021 Q2	$3.87M	Sell	46,066 -203,934	-82%	-$13.5M	0.31%	80
2021 Q1	$12.1M	Buy	250,000 +100,000	+67%	+$5.43M	0.41%	57
2020 Q4	$7.07M	Hold	150,000	–	–	0.31%	74
2020 Q3	$7.05M	Buy	+150,000	New	+$4.95M	0.51%	50

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Cederberg Capital London, United Kingdom $186M AUM 21.27% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ZAM

Zeal Asset Management Central, Hong Kong $39.4M AUM 38.83% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Ikarian Capital's NBP Position: Q3 2021 in Review

Ikarian Capital sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q3 2021, closing a stake of 46,066 shares — an estimated $3.87M sold.

Ikarian Capital first reported a position in NBP in Q3 2020 and held it in 4 quarters. The position peaked at $12.1M in Q1 2021. 144 funds tracked by Wall St. Rank hold NBP as of Q3 2021.

Ikarian Capital reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q3 2021 after selling out during the quarter.
Ikarian Capital sold 46,066 NovaBridge Biosciences American Depositary Shares shares in Q3 2021, an estimated $3.87M.
Ikarian Capital first reported a position in NovaBridge Biosciences American Depositary Shares in Q3 2020 and held it in 4 quarters.
Ikarian Capital's NovaBridge Biosciences American Depositary Shares position peaked at $12.1M in Q1 2021.
144 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q3 2021.

Based on Ikarian Capital's 13F filing for Q3 2021, filed 15 Nov 2021.